الرئيسية/أخبار/Press Releases/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Press ReleasesأخبارTIF News (AR) TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders أقل من دقيقة 211020_ TIF Announcement_COVID-19 Vaccine Boosters الوسومCOVID-19 Vaccines Sickle cell Vulnerable #news TIF News COVID-19 Pandemic COVID-19 Vaccinations Haemoglobin Disorders Thalassaemia Patients Healthcare Professionals AtRisk أقل من دقيقة فيسبوك X لينكدإن مشاركة عبر البريد طباعة
